Cannabis and Cannabinoids in Adults with Canc...

Dr. Sonam Puri discusses the full update to the living guideline on stage IV NSCLC with driver alterations. She shares a new overarching recommendation on biomarking testing and explains the new recommendations and the supporting evidence for first-line and subsequent therapies f ...  Show more

Dr. Joshua Reuss is back on the podcast to discuss the full update to the living guideline on stage IV NSCLC without driver alterations. He discusses the new evidence and how this impacts the latest recommendations on first-line and subsequent therapeutic options. Dr. Reuss empha ...  Show more

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Vamsi Velcheti, Taofeek Owonikoko, and Janakiraman Subramanian discuss their experiences navigating the cancer drug shortage in the United States, the impact on patients and clinical trial enrollme ...

You’ve probably heard of these letters: THC, CBD, but what about  CBG or CBN, how about terpenes, or phytocannabinoids?What do they really mean and how can we optimize our experience with them.Now you may be thinking this is a weed show for stoners, but it’s not. Not even close!T ...  Show more

Dr. Pennell talks with Dr. Ray Page about efforts to address the opioid crisis impact onthe care of patients, and what role oncologists can play on this issue. Hello, and welcome to the ASCO Journal of Oncology Practice podcast. This is Dr. Nate Pennell, medical oncologist at the ...  Show more

Cannabis has several medicinal uses and is legal in several states. More and more patients are using cannabis as a medication for anxiety, pain management, and for recreational use.

In this episode, Jeremy and Sass discuss the pharmacodynamics of cannabis and focus on t ...